AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01336322 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: Metformin 850 mg bid
Study NCT02297789 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Investigative Full Face Mask with Headgear
Study NCT01336322 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sitagliptin
Description: Sitagliptin 100 mg qd
Study NCT01336322 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sitagliptin + Metformin
Description: sitagliptin 100mg + metformin 850mg
Study NCT03781557 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid
Description: High-concentrated DHA
Study NCT03781557 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid
Description: High-concentrated EPA
Study NCT03781557 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Olive oil
Description: Olive Oil softgels
Study NCT01974791 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: GET Living
Description: GET Living is an exposure based treatment jointly delivered by a cognitive-behavioral therapist and physical therapy to help children and adolescents suffering with chronic pain and headache progressively return to valued life activities.
Study NCT01935219 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Goal Management Training
Description: 9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer
Study NCT01935219 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Processing Speed Training
Description: 9 weeks, a total of 10 hours of computer-based processing speed training; 60-75 minutes/week
Study NCT01935219 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Processing Speed Training
Description: 9 weeks, a total of 10 hours of computer-based processing speed training; 60-75 minutes/week
Study NCT01935219 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Brain Health Workshop
Description: 9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer
Study NCT01935219 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brain Health Workshop
Description: 9 weeks, 2 hour session/week, 1 hour/day homework (6 days/week), 2 x 0.5 hour sessions with trainer
Study NCT03399461 — intervention group
Intervention type: OTHER
Intervention: Patient Interview guide
Description: The interviewer will conduct the interview for subjects with WAS using a semi-structured patient interview guide.
Study NCT03399461 — intervention group
Intervention type: OTHER
Intervention: Caregiver interview guide
Description: The interviewer will conduct the interview for caregivers of subjects with WAS using a semi-structured caregiver interview guide.
Study NCT03399461 — intervention group
Intervention type: OTHER
Intervention: Sociodemographic questionnaire
Description: At the end of interview, subjects will be required to complete subject or caregiver versions of country-specific sociodemographic questionnaire.
Study NCT02406261 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: 250 mcg midazolam will be administered intravenous (IV) as 0.25 mL of 1-mg/mL injection solution
Study NCT02406261 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil
Description: 5 mg donepezil will be administered orally as 1 × 5-mg tablet
Study NCT03016117 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pecs II block and parasternal block
Description: The Pecs II block will be performed under ultrasound guidance, at fourth rib level, on the axillary line, into the fascial plane between pectoralis minor muscle and serratus muscle. The parasternal block will be performed under ultrasound guidance, at the second and fourth intercostal space, between the pectoralis major muscle and the intercostal muscles, near to the external intercostal membrane.
Study NCT03753711 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multifidus muscle biopsy during minimally invasive back surgery
Description: Bilateral biopsy of the multifidus muscle in patient with a unilateral disc hernia.
Study NCT04892056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Frictionless Mechanics
Description: anterior segment retraction using closing loops
Study NCT03993899 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: FineHearing strategy or HDCIS strategy
Description: Cochlear implant with FineHearing strategy or HDCIS strategy
Study NCT03399461 — intervention group
Intervention type: OTHER
Intervention: Pediatric quality of life (PedsQL) questionnaire
Description: The PedsQL is a validated generic measure of health-related quality of life (HRQOL) in children, adolescents, and young adults with acute and chronic health conditions. At the end of interview, subjects will be required to complete subject or caregiver versions of PedsQL questionnaire.
Study NCT03653260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine (Zingo)
Description: 0.5 mg lidocaine, 20 bar pressure
Study NCT03653260 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo injector, 20 Bar pressure, empty injector
Study NCT02381834 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bladder stimulation technique
Study NCT03360305 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: GAPcare intervention
Description: Subjects will receive PT and pharmacist evaluation. PT will help determine whether subject may benefit from doing exercises to improve strength or balance. PT may also supply subject with an assist device. A pharmacist will ask patient about any medication they are taking and will make recommendations on how their medication could be changed to prevent falls. Pharmacists will communicate this information to subject's doctors. Subjects will receive a fall calendar for home, where they will record any falls they have after their discharge from the ED. They will receive a phone call at home asking about any recent falls and health care interactions. Study personnel will call subjects every 2 weeks for 6 months. Subjects may receive a referral for outpatient or home-based physical and occupational therapy at the end of the visit.
Study NCT03399461 — intervention group
Intervention type: OTHER
Intervention: Clinical questionnaire
Description: At the end of interview, subjects will be required to complete subject or caregiver versions of clinical questionnaire.
Study NCT04562103 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine / Ropivacaine
Description: In this group quadratus lomborum block was performed with 0.375% ropivacaine+100 mcg epinephrine.
Study NCT04562103 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: In this group quadratus lomborum block was performed with plane 0.375% ropivacaine.
Study NCT03981601 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lovastatin 40 MG
Description: after tooth extraction, put teh lovastatin40 mg wif bone graft wifin tooth socket
Study NCT03981601 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: without drug with Bone graft
Description: after tooth extraction, put teh bone graft wifin tooth socket
Study NCT03088514 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beetroot juice
Description: Beetroot juice (70ml daily) with or without inorganic nitrate
Study NCT03088514 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Beetroot juice
Description: Beetroot juice (70ml daily) with or without inorganic nitrate
Study NCT02691000 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LiteBook
Description: Light therapy using a Bright White Light Litebook for 1 hour each morning for 8 weeks. This is the experimental intervention.
Study NCT02691000 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: LiteBook
Description: Light therapy using a Dim Red Light Litebook for 1 hour each morning for 8 weeks. This is the control.
Study NCT06231784 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: LUMINA IOL
Description: A standard technique of phacoemulsification was performed followed by implantation of the Lumina in the sulcus plane of the eye by using a standard disposable injector system with an adapted, proprietary, AkkoLens butterfly cartridge.
Study NCT02694731 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile application intervention (Device: Smartphone)
Description: Consists of the app described in the arm description.
Study NCT04567056 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sample
Description: A separate blood sample will be taken for methylation-analyses
Study NCT01151137 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dronedarone
Description: Film-coated tablet~Oral administration under fed conditions (during breakfast and dinner)
Study NCT01151137 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (for Dronedarone)
Description: film-coated tablet strictly identical in appearance~Oral administration under fed conditions (during breakfast and dinner)
Study NCT02600299 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation group
Description: On the basis of previous studies that evaluated PEG interventions for women with breast cancer, a structured program based on the Cognitive Behavioral Therapy (CBT) principles was developed. Patients in the PEG group will be involved in three sessions of psychoeducation. The PEG program is designed to cover the various aspects outlined by the IOM on quality cancer survivorship.
Study NCT02600299 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Usual Care
Description: Usual Care
Study NCT04409678 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: activity
Description: physical activity
Study NCT04256928 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Preoperative electrical clipping
Description: Body hair in the operative field will be clipped with an electrical clipper by hospital personnel during preparation to planned surgery.
Study NCT03604666 — intervention group
Intervention type: OTHER
Intervention: Health care process with Nurse Navigator
Description: A Nurse Navigator will:~* Be present at the announcement consultation~* Give information on the outpatient circuit~* Offer assistance for patients over 75 years~* Complete onco-geriatric orientation questionnaires~* Take care of patients on the ambulatory circuit
Study NCT00519870 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: nifedipine, losartan
Description: I: nifedipine 30 mg/d II: losartan 50 mg/d
Study NCT00519870 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: losartan
Description: II: losartan
Study NCT00519870 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nifedipine, losartan
Description: I: nifedipine II: losartan
Study NCT01381081 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: platelet-rich plasma
Description: a single intra-articular injection
Study NCT01381081 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid
Description: A single betamethasone and bupivacaine intra-articular injection
Study NCT02656472 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid
Description: TXA Loading dose: 31 mg/kg diluted to 2 ml/kg Normal saline (NS) -in syringe
Study NCT02656472 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epsilon Aminocaproic Acid
Description: Aminocaproic acid Loading dose: 75 mg/kg diluted to 2 ml/kg NS
Study NCT02743858 — intervention group
Intervention type: OTHER
Intervention: Bilateral arm measurements
Description: Pts treated with ALND, bilateral arm measurements will be obtained using the Perometer (Model 350 NT Perometer, Per-System) circumferential arm measurements with elastic tape taken at 4-cm intervals from the wrist to the shoulder \& the L-Dex U400 (Impedimed, Brisbane, Australia) for bioimpedance measurements. Measurements will be performed before surgery, post-operatively \& at timepoints of 6,12,18, \& 24 months after surgery for 2 years will be obtained using the Perometer (Model 350 NT Perometer, Per-System) for bioimpedance measurements. Pts who have not yet developed lymphedema by 2 years, an additional measurement at approx 3 years post-surgery will be performed. If pt is diag with lymphedema at the 3-year visit, she will be asked to continue on study for an additional year. Pts treated with SLNB alone, following re-consent, a long-term follow-up volumetric arm measurement will be obtained using the perometer \& circumferential arm measurements at a minimum of 2 years post-surgery.
Study NCT02743858 — intervention group
Intervention type: OTHER
Intervention: Body mass index (BMI)
Description: Height and weight will be obtained for each patient at baseline and at each scheduled visit for the purpose of calculating BMI. BMI will be correlated with the presence of inflammatory biomarkers in the tissue, as well as with lymphedema development.
Study NCT02743858 — intervention group
Intervention type: BEHAVIORAL
Intervention: Quality of Life Questionnaire
Study NCT02743858 — intervention group
Intervention type: OTHER
Intervention: Blood draw
Description: Patients enrolled in the translational study (Cohort 3) will undergo blood draws for serum collection preoperatively and 12-24 months postoperatively to test for FGF2, IL4, IL10, TGFB, Leptin, IL6, and CRP. At both timepoints, up to 20 mL of blood will be collected.
Study NCT04314505 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Opioid-Sparing Protocol
Description: After a general anesthesia procedure was performed, an experienced anesthesiologist performed ultrasound guided adductor canal block procedures on both knees. In the opioid-sparing group, a dose of Parecoxib sodium 40 mg was administrated through intravenous route before the incision. After the surgery, Parecoxib sodium 40 mg was given intravenously every 12 hours for 4 more doses. Before the wound closure, the periarticular injection (each side 10 ml of 0.25% Bupivacaine) was done. The total dosage would be recorded in the device. All patients received oral paracetamol 500mg, 4 times a day and oral celecoxib 200mg, 2 times a day after surgery.
Study NCT03626298 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Adapalene
Description: third-generation topical retinoid primarily used in the treatment of mild-moderate acne. It is effective against acne conditions where comedones are predominant.
Study NCT01947023 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo tumor biopsy
Study NCT01947023 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT01947023 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT01947023 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabrafenib
Description: Given PO
Study NCT01947023 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabrafenib Mesylate
Description: Given PO
Study NCT01947023 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO
Study NCT01947023 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lapatinib
Description: Given PO
Study NCT01947023 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lapatinib Ditosylate
Description: Given PO
Study NCT01947023 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT01947023 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA
Study NCT01947023 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET
Study NCT01559909 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vacuum assisted socket technology (Harmony System, Otto Bock Healthcare)
Description: The brim height of the socket will be systematically reduced
Study NCT01938157 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Diffusion-weighted MR imaging
Description: An addition 90 seconds of DWI will be added to a clinical breast MRI for all patients agreeing to participate in the study.
Study NCT04265066 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: microcirculation
Description: measurement of microcirculation
Study NCT02583984 — intervention group
Intervention type: PROCEDURE
Intervention: Thoracic Surgery with Lung Resection
Description: General anesthesia and lung separation Thoracic surgery with lung resection, such as lobectomy, segmentectomy
Study NCT02583984 — intervention group
Intervention type: PROCEDURE
Intervention: Thoracic Surgery without Lung Resection
Description: General anesthesia and lung separation Thoracic surgery without lung resection, such as esophageal surgery, mediastinal surgery
Study NCT04617808 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: The regulatory scheme applied to all investigative centers is as follows:~* Call from Center 15 by a major patient for secondary headache no traumatic. (i.e. not having been the victim of a head trauma during the 48 hours preceding the call)~* Detection of the pattern of non-traumatic headache, by the regulatory assistant medical with registration of the word cephareg in the medical regulation software in order to alert the regulator about the possible inclusion of the patient~* If possible, patient information on the collection of their data for research and possibility of opposing~* Filling of a medical questionnaire by the regulating doctor~* Weekly collection of medical questionnaires by investigating doctors
Study NCT04644848 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasonographical tattooing of suspicious axillary lymph nodes.
Description: Patients with clinically negative axillae scheduled for sentinel lymph node biopsy (SLNB) will have axillary ultrasonographical imaging of the ipsilateral axilla with a high-frequency linear probe. Suspicious lymph nodes are identified according to any of the following criteria:~* Round shape.~* Cortical thickness > 3 mm~* Eccentric cortical thickness.~* Loss of hilum.~For each patient, node dimensions and the presence of each of the above-mentioned criteria are recorded. Tattooing of all suspicious nodes is done using I ml of sterile liquid charcoal.
Study NCT04644848 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy
Description: Sentinel node biopsy is performed with peri-areolar subdermal injection of 3 ml methylene blue 5%. The lymphatics are tracked to the first blue lymph node. All blue, enlarged and /or tattooed nodes are separately biopsied and labelled as SLN and/or tattooed node.
Study NCT04644848 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Histopathological examination of the axillary nodes
Description: All tattooed nodes are excised and sent to frozen section examination; labelled tattoo node.~All enlarged or blue stained nodes are excised and sent to frozen section examination; labelled sentinel node.~All nodes are bisected and a single 5 um section examined. All frozen section examinations are followed by routine paraffin section examination.
Study NCT04644848 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Further axillary management
Description: Further axillary management is performed as per institutional guidelines. If SLNB is negative, no further surgery is required. Axillary lymph node dissection is performed if sentinel lymph node is positive or not identified. Management of positive SLNB as per the American College Of Surgeons' Oncology Group (ACOSOG) Z0011 protocol is not currently adopted on routine basis at the investigators' institution. In this study, patients with tattooed nodes with positive histopathological findings are offered full axillary dissection even if their sentinel nodes are negative.
Study NCT02272192 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early Start Denver Model (ESDM)
Description: The Early Start Denver Model (ESDM) is a comprehensive developmental and behavioral early intervention approach for children with autism, ages 12 to 48 months. The program encompasses a developmental curriculum that defines the skills to be taught at any given time and a set of teaching procedures based in applied behavioral analysis to deliver this content. The teaching format focuses on trained therapists delivering the intervention 1:1 by engaging reciprocally with children in typical toddler activities involving play or daily routines, adding additional structure for children who need it to progress well. Progress data is collected throughout each session and used to make decisions about teaching approaches.
Study NCT02272192 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early Intensive Behavioral Intervention (EIBI)
Description: EIBI is a one-to-one instructional approach based in applied behavior analysis used to teach skills in a planned, controlled, and systematic manner. Each trial or teaching opportunity has a definite beginning and end, thus the descriptor discrete trial. Within DTT, the use of antecedents and consequences is carefully planned and implemented. Positive praise and/or tangible rewards are used to reinforce desired skills or behaviors. Trial by trial data collection is an important part of DTT and supports decision making by providing teachers/practitioners with information about beginning skill level, progress and challenges, skill acquisition and maintenance, and generalization of learned skills or behaviors.
Study NCT00880750 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate Granule Formulation
Description: 3x's per day for 3 days, 1 dose in the am for day 4. (A single dose equals 1000mg of lanthanum carbonate granule formulation. Dose is administered immediately after each meal.)